These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 22178574

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Beta2-glycoprotein I dependent anticardiolipin antibodies and lupus anticoagulant in patients with recurrent pregnancy loss.
    Kumar KS, Jyothy A, Prakash MS, Rani HS, Reddy PP.
    J Postgrad Med; 2002; 48(1):5-10. PubMed ID: 12082318
    [Abstract] [Full Text] [Related]

  • 4. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
    Saccone G, Berghella V, Maruotti GM, Ghi T, Rizzo G, Simonazzi G, Rizzo N, Facchinetti F, Dall'Asta A, Visentin S, Sarno L, Xodo S, Bernabini D, Monari F, Roman A, Eke AC, Hoxha A, Ruffatti A, Schuit E, Martinelli P, PREGNANTS (PREGNancy in women with ANTiphospholipid Syndrome) working group.
    Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
    [Abstract] [Full Text] [Related]

  • 5. Anticardiolipin and anti-beta2 glycoprotein I antibodies and lupus-like anticoagulant: prevalence and significance in systemic sclerosis.
    Marie I, Jouen F, Hellot MF, Levesque H.
    Br J Dermatol; 2008 Jan; 158(1):141-4. PubMed ID: 18028496
    [Abstract] [Full Text] [Related]

  • 6. Antiphospholipid and antiprotein syndromes in non-thrombotic, non-autoimmune women with unexplained recurrent primary early foetal loss. The Nîmes Obstetricians and Haematologists Study--NOHA.
    Gris JC, Quéré I, Sanmarco M, Boutiere B, Mercier E, Amiral J, Hubert AM, Ripart-Neveu S, Hoffet M, Tailland ML, Rousseau O, Monpeyroux F, Dauzat M, Sampol J, Daures JP, Berlan J, Marès P.
    Thromb Haemost; 2000 Aug; 84(2):228-36. PubMed ID: 10959694
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML, Atsumi T, Escudero Contreras A, Khamashta MA, Hughes GR.
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [Abstract] [Full Text] [Related]

  • 9. Immunoglobulin A anti-beta2-glycoprotein antibodies in women who experience unexplained recurrent spontaneous abortion and unexplained fetal death.
    Lee RM, Branch DW, Silver RM.
    Am J Obstet Gynecol; 2001 Sep; 185(3):748-53. PubMed ID: 11568809
    [Abstract] [Full Text] [Related]

  • 10. Prevalence and clinical usefulness of antiphospholipid and anticofactor antibodies in different Spanish preeclampsia subsets.
    Ferrer-Oliveras R, Llurba E, Cabero-Roura L, Alijotas-Reig J.
    Lupus; 2012 Mar; 21(3):257-63. PubMed ID: 22065091
    [Abstract] [Full Text] [Related]

  • 11. High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndrome.
    Simchen MJ, Dulitzki M, Rofe G, Shani H, Langevitz P, Schiff E, Pauzner R.
    Acta Obstet Gynecol Scand; 2011 Dec; 90(12):1428-33. PubMed ID: 21729009
    [Abstract] [Full Text] [Related]

  • 12. Autoantibody explosion in antiphospholipid syndrome.
    Shoenfeld Y, Twig G, Katz U, Sherer Y.
    J Autoimmun; 2008 Dec; 30(1-2):74-83. PubMed ID: 18171610
    [Abstract] [Full Text] [Related]

  • 13. Primary, secondary, and catastrophic antiphospholipid syndrome: what's in a name?
    Harris EN, Pierangeli SS.
    Semin Thromb Hemost; 2008 Apr; 34(3):219-26. PubMed ID: 18720301
    [Abstract] [Full Text] [Related]

  • 14. Anti-beta2-glycoprotein I antibodies are associated with pregnancy loss in women with the lupus anticoagulant.
    Sailer T, Zoghlami C, Kurz C, Rumpold H, Quehenberger P, Panzer S, Pabinger I.
    Thromb Haemost; 2006 May; 95(5):796-801. PubMed ID: 16676070
    [Abstract] [Full Text] [Related]

  • 15. Association between antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis.
    Opatrny L, David M, Kahn SR, Shrier I, Rey E.
    J Rheumatol; 2006 Nov; 33(11):2214-21. PubMed ID: 17014001
    [Abstract] [Full Text] [Related]

  • 16. Pathogenic antibodies in women with obstetric features of antiphospholipid syndrome who have negative test results for lupus anticoagulant and anticardiolipin antibodies.
    Silver RM, Pierangeli SS, Edwin SS, Umar F, Harris EN, Scott JR, Branch DW.
    Am J Obstet Gynecol; 1997 Mar; 176(3):628-33. PubMed ID: 9077618
    [Abstract] [Full Text] [Related]

  • 17. A comprehensive screening analysis of antiphospholipid antibodies in Indian women with fetal loss.
    Vora S, Shetty S, Salvi V, Satoskar P, Ghosh K.
    Eur J Obstet Gynecol Reprod Biol; 2008 Apr; 137(2):136-40. PubMed ID: 17644242
    [Abstract] [Full Text] [Related]

  • 18. Antiphospholipid syndrome: critical analysis of the diagnostic path.
    Pengo V, Banzato A, Bison E, Denas G, Padayattil Jose S, Ruffatti A.
    Lupus; 2010 Apr; 19(4):428-31. PubMed ID: 20353982
    [Abstract] [Full Text] [Related]

  • 19. The prevalence of antiphospholipid antibodies in women with reproductive failure or major abruptio placentae.
    van der Spuy ZM, Bird AR, Lindow SW, Bruce C.
    S Afr Med J; 1993 May; 83(5):319-21. PubMed ID: 8211423
    [Abstract] [Full Text] [Related]

  • 20. Clinical consequences of antiphospholipid antibodies.
    Derksen RH, de Groot PG.
    Neth J Med; 2004 Sep; 62(8):273-8. PubMed ID: 15588067
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.